Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Immunotech Biopharm Ltd ( (HK:6978) ).
Immunotech Biopharm Ltd has announced its upcoming Annual General Meeting (AGM) scheduled for May 23, 2025, in Beijing, China. The meeting will address several key resolutions including the adoption of financial statements, re-election of directors, and granting a mandate to the board for share issuance. These resolutions are crucial for the company’s governance and strategic planning, potentially impacting its market operations and investor relations.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. It focuses on developing and commercializing innovative therapies, with a market focus likely on healthcare and biotechnology sectors.
YTD Price Performance: 70.87%
Average Trading Volume: 840,465
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.02B
See more insights into 6978 stock on TipRanks’ Stock Analysis page.